Showing results (1511-1520 of 9,924) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|April 1, 1999
Ifosfamide and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphomaJ Mayer, Z Korístek, I Vásová, et al.
Bone Marrow Transplantation|April 1, 1999
A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitoninM J Välimäki, K Kinnunen, L Volin, et al.
Bone Marrow Transplantation|April 1, 1999
Progressive multifocal leucoencephalopathy with peripheral demyelinating neuropathy after autologous bone marrow transplantation for acute myeloblastic leukemia (FAB5)P Coppo, J P Laporte, M Aoudjhane, et al.
Bone Marrow Transplantation|April 1, 1999
Successful human umbilical cord blood stem cell transplantation without conditioning in severe combined immune deficiencyA Toren, A Nagler, N Amariglio, et al.
Bone Marrow Transplantation|April 25, 2001
Successful unrelated donor bone marrow transplantation for paroxysmal nocturnal hemoglobinuriaP Woodard, W Wang, N Pitts, et al.
Bone Marrow Transplantation|April 25, 2001
Human gammadelta(+) T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic responseL S Lamb, P Musk, Z Ye, et al.
Bone Marrow Transplantation|April 25, 2001
Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathyO Rosen, G Massenkeil, F Hiepe, et al.
Bone Marrow Transplantation|April 21, 2001
Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patientsN Kröger, T Zabelina, W Krüger, et al.
Bone Marrow Transplantation|April 21, 2001
Kinetic analysis of cytokine gene expression in patients with GVHD after donor lymphocyte infusionH Das, S Imoto, T Murayama, et al.
Bone Marrow Transplantation|April 21, 2001
A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphomaT Endo, T Sakai, K Fujimoto, et al.
Pageof 993